MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B

Journal of Medical Virology

Volumn 86, Issue 3, 2014, Pages 446-453

  Kim, Hwi Young ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a   Cheong, Jae Youn ^b   Cho, Sung Won ^b   Shin, Hyoung Doo ^c   Kim, Yoon Jun ^a  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sogang University   (South Korea)

Author keywords

Hepatitis B; Liver cancer; MicroRNA; Polymorphism

Indexed keywords

MICRORNA; MICRORNA 196A 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CODOMINANCE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

HEPATITIS B VIRUS;

HEPATITIS B; LIVER CANCER; MICRORNA; POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE RESISTANCE; FEMALE; GENE FREQUENCY; GENOTYPING TECHNIQUES; HEPATITIS B, CHRONIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84891926518     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23848     Document Type: Article

References (46)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LSt, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger Y. 2011. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study. J Viral Hepat 18:e399-e407.
3. Aravalli RN, Steer CJ, Cressman EN. 2008. Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:2047-2063.
4. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
5. Braconi C, Patel T. 2008. MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 47:1807-1809.
6. Bruix J, Sherman M. 2011. Management of hepatocellular carcinoma: An update. Hepatology 53:1020-1022.
7. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. 2011. MicroRNA in prostate, bladder, and kidney cancer: A systematic review. Eur Urol 59:671-681.
8. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. 2008. Polymorphisms in microRNA targets: A gold mine for molecular epidemiology. Carcinogenesis 29:1306-1311.
9. Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L. 2011. Intracellular and extracellular microRNAs in breast cancer. Clin Chem 57:18-32.
10. Coursaget P, Yvonnet B, Chotard J, Vincelot P, Sarr M, Diouf C, Chiron JP, Diop-Mar I. 1987. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 22:1-5.
11. He L, Hannon GJ. 2004. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531.
12. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. 2009. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 69:5970-5977.
13. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H. 2009. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79-84.
14. Huang S, He X. 2011. The role of microRNAs in liver cancer progression. Brit J Cancer 104:235-240.
15. Jung YJ, Kim YJ, Kim LH, Lee SO, Park BL, Shin HD, Lee HS. 2007. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Intervirology 50:369-376.
16. KASL. 2012. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol 18:109-162.
17. Kent OA, Mendell JT. 2006. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188-6196.
18. Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ. 2011. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence. Dig Dis 29:278-283.
19. Kim LH, Shin HD, Park BL, Jung JH, Kim JY, Kim YJ, Lee HS. 2003a. Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients. Hum Mutat 21:652-653.
20. Kim MJ, Yoo SS, Choi YY, Park JY. 2010a. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 69:127-129.
21. Kim YJ, Kim HY, Kim JS, Lee JH, Yoon JH, Kim CY, Park BL, Cheong HS, Bae JS, Kim S, Shin HD, Lee HS. 2010b. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Viral Hepat 17:518-526.
22. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD. 2003b. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 12:2541-2546.
23. Kim YJ, Yoon JH, Kim CY, Kim LH, Park BL, Shin HD, Lee HS. 2006. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun 346:38-44.
24. Li XD, Li ZG, Song XX, Liu CF. 2010. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42:669-673.
25. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, Lin CC, Kwang TY, Hsu ST, Lin SY, Hsu LC. 1989. Hepatitis B virus markers in Chinese twins. Anticancer Res 9:737-741.
26. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14:143-149.
27. Lok AS, McMahon BJ. 2007. Chronic hepatitis B. Hepatology 45:507-539.
28. Lok AS, McMahon BJ. 2009. Chronic hepatitis B: Update 2009. Hepatology 50:661-662.
29. Mott JL. 2009. MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia. Hepatology 50:630-637.
30. O'Mara TA, Clements JA, Spurdle AB. 2009. The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: Justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors. Cancer Epidemiol Biomarkers Prev 18:2352-2365.
31. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I. 2010. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15:524-531.
32. Park BL, Kim YJ, Cheong HS, Kim LH, Choi YH, Lee HS, Shin HD. 2006. Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp Mol Med 38:694-702.
33. Park TJ, Chun JY, Bae JS, Park BL, Cheong HS, Lee HS, Kim YJ, Shin HD. 2010. CCND2 polymorphisms associated with clearance of HBV infection. J Hum Genet 55:416-420.
34. Pasaje CF, Kim JH, Park BL, Cheong HS, Bae JS, Park TJ, Lee JS, Kim Y, Lee HS, Koh I, Kim YJ, Shin HD. 2011. Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population. J Med Virol 83:1892-1899.
35. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q. 2010. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55:2288-2293.
36. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. 2006. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529-538.
37. Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang H, Gao CF. 2010. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71:621-626.
38. Ryan BM, Robles AI, Harris CC. 2010. Genetic variation in microRNA networks: The implications for cancer research. Nat Rev Cancer 10:389-402.
39. Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS. 2007. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol 36:1001-1008.
40. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, Kim YJ, Lee HS. 2003. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12:901-906.
41. Song B, Ju J. 2010. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med 12:e33.
42. Stevens CE, Beasley RP, Tsui J, Lee WC. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292:771-774.
43. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. 1987. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 92:1844-1850.
44. Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H. 2009. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 18:1183-1187.
45. Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W, Wu J. 2011. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: A meta-analysis. PLoS ONE 6:e20471.
46. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, Chen PJ, Hsiao TJ, Lee PH, Chen CJ. 2000. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92:1159-1164.